Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial.
Journal article
Johansen ND. et al, (2024), Clin Microbiol Infect
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health
Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease
Journal article
Mayne K. et al, (2023), Journal of the American Society of Nephrology
Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2023), Lancet Child and Adolescent Health
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
PETO L. et al, (2023), Nature Communications
Impact of Primary Kidney Disease on the Effects of Empagliflozin in Patients with Chronic Kidney Disease: Secondary Analyses of the EMPA-KIDNEY trial
Journal article
Judge P. et al, (2023), Lancet Diabetes and Endocrinology
Delivering trials in the NHS: more than worth it.
Journal article
Haynes R. et al, (2023), Clin Med (Lond), 23, 525 - 526
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2023), Lancet Diabetes and Endocrinology
Reliability of major bleeding events in UK routine data vs clinical trial adjudicated follow-up data
Journal article
MAFHAM M. et al, (2023), Heart
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)
Journal article
HERRINGTON W. et al, (2023), Kidney International Reports
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
Horby PW. et al, (2023)
Fast tracking informative clinical trials: lessons for mental health.
Journal article
Gold SM. et al, (2023), Lancet Psychiatry
Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2023), The Lancet
Facilitating participation in clinical trials during pregnancy.
Journal article
Vousden N. et al, (2023), BMJ, 380
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors.
Journal article
Chapman D. et al, (2023), Kidney Int
A Pragmatic Randomized Feasibility Trial of Influenza Vaccines
Journal article
Johansen ND. et al, (2023), NEJM Evidence, 2
Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.
Journal article
Bowman L. et al, (2022), Eur Heart J
Empagliflozin in Patients with Chronic Kidney Disease
Journal article
HERRINGTON W. et al, (2022), New England Journal of Medicine